Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis. | PLoS One | 2022 | 35045126 | PubTator, text mining | PubMed |
| Cytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations. | RNA | 2022 | 35031583 | PubTator, text mining | PubMed |
| Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. | Nat Genet | 2022 | 35027740 | PubTator, text mining | PubMed |
| Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures. | EBioMedicine | 2022 | 35027333 | PubTator, text mining | PubMed |
| Presence of Uterine Leiomyomas Has No Significant Impact on Gene Expression Profile in the Scalp of Patients with Central Centrifugal Cicatricial Alopecia. | JID Innov | 2022 | 35024684 | PubTator, text mining | PubMed |
| Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells. | iScience | 2022 | 35024587 | PubTator, text mining | PubMed |
| Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease. | J Crohns Colitis | 2022 | 35022690 | PubTator, text mining | PubMed |
| Role of helical structure and dynamics in oligoadenylate synthetase 1 (OAS1) mismatch tolerance and activation by short dsRNAs. | Proc Natl Acad Sci U S A | 2022 | 35017296 | PubTator, text mining | PubMed |
| Host genetic factors of COVID-19 susceptibility and disease severity in a Thai population. | J Hum Genet | 2022 | 35013560 | PubTator, text mining | PubMed |
| Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression. | Transl Psychiatry | 2022 | 35013133 | PubTator, text mining | PubMed |
| Skin Injury Activates a Rapid TRPV1-Dependent Antiviral Protein Response. | J Invest Dermatol | 2022 | 35007556 | PubTator, text mining | PubMed |
| CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1. | EBioMedicine | 2022 | 34998241 | PubTator, text mining | PubMed |
| Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive. | Sci Rep | 2022 | 34997119 | PubTator, text mining | PubMed |
| Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development. | J Mol Biol | 2022 | 34990653 | PubTator, text mining | PubMed |
| Transcriptomics of receptive endometrium in women with sonographic features of adenomyosis. | Reprod Biol Endocrinol | 2022 | 34980152 | PubTator, text mining | PubMed |
| Local and systemic responses to SARS-CoV-2 infection in children and adults. | Nature | 2022 | 34937051 | PubTator, text mining | PubMed |
| Comprehensive analysis of epigenetic modifications and immune-cell infiltration in tissues from patients with systemic lupus erythematosus. | Epigenomics | 2022 | 34913398 | PubTator, text mining | PubMed |
| Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults. | iScience | 2022 | 34904133 | PubTator, text mining | PubMed |
| Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication. | iScience | 2022 | 34877479 | PubTator, text mining | PubMed |
| In situ analysis of variations of arsenicals, microbiome and transcriptome profiles along murine intestinal tract. | J Hazard Mater | 2022 | 34876320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=36